SB
Background
CFO at Saltford Pharma, where I'm scaling the finance function through our Series B. Previously CFO at Wintergreen Biotech and Stellaris Bio, with earlier finance leadership roles at Embercast Bio, Tessera Therapeutics UK and Linden Pharma. Fifteen years in UK oncology and rare-disease biotech, with a particular intere…
Experience32 yrsCompanies8
Career History
Nov 2025 – Present8 moChief Financial Officer at Saltford PharmaLondon, England, United Kingdom
Series A → Series B prep24 → 41 FTEsOncology · Small molecules
Sitting CFO running the Series B process at a 41-person UK oncology biotech — clean reference fit, only 14 months in seat.
Nov 2025 – Present8 moChief Financial Officer at Wintergreen Biotech
Series A11–50 FTEs£9M Series A extension
Led the £9M Series A extension at a 22-person UK drug-development biotech, closing alongside Mercia and SV Health.
Jan 2022 – Mar 20231 yr 2 moChief Financial Officer at Stellaris BioLondon, England, United Kingdom
Seed → Series A4 → 19 FTEs£18M Series A (Abingworth-led)Built finance from blank page
Joined as first finance hire, built the function from zero and led the £18M Abingworth-led Series A inside 14 months.
Jul 2021 – May 20253 yr 10 moFinance Director at Embercast BioLondon, England, United Kingdom
Education
Bachelor's degree — Northbridge University (1979–1983)